The largest database of trusted experimental protocols

Crtac ncr foxn1nu

Manufactured by Taconic Biosciences
Sourced in United States

CrTac:NCr-Foxn1nu is a genetically engineered mouse model developed by Taconic Biosciences. It carries a mutation in the Foxn1 gene, which is responsible for the development of the thymus. This model is commonly used in research applications involving immunodeficiency and transplantation studies.

Automatically generated - may contain errors

19 protocols using crtac ncr foxn1nu

1

Athymic Mouse Tumor Model Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal procedures were performed according to a protocol approved by Northeastern University, Institutional Animal Care and Use Committee (NUIACUC). Five to six weeks old female nu/nu (athymic) mice, strain CrTac:NCr-Foxn1nu, weighing approximately 20 g, were purchased from Taconic Biosciences, Inc. (Hudson, NY). The animals were allowed to acclimate for at least 72 h prior to any experimentation, raised under specific pathogen-free conditions, kept in individually ventilated cage racks and supplied with sterile rodent pellets and water ad libitum. Mice were housed under a 12 h light/dark cycle.
For A549-WT and A549-DDP tumor model development, mice were injected subcutaneously with 3×106 cells in a mixture of 50 µL DMEM/F12 medium and 50 µL Matrigel under mild anesthesia on their right flank. Tumor volume was calculated by the modified ellipsoid formula: tumor volume = 1/2(length × width2). When tumors grew to approximately 200 ± 20 mm3 in volume the animals were randomized into groups to yield even distribution of tumor sizes. Sample size was determined by power analysis using the software G*Power. Each animal was identified with an ear tag which allowed us to perform blind experiments in order to reduce bias in animal selection and outcome assessment. The animals were monitored daily for food/water intake, body weight and any physical signs of discomfort.
+ Open protocol
+ Expand
2

Xenograft Tumor Growth Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All studies involving animals were performed according to approved IACUC protocols at the City of Hope Cancer Center. 2 × 106 MEF E1A-RAS cells stably expressing empty vector or shSlc7a3 were injected into the right flank of randomly assigned CrTac:Ncr-Foxn1nu (Taconic) mice. Tumors were established subcutaneously in 8–12 wk-old male mice. Tumor growth was measured over time using the formula ½ (length × width2).
+ Open protocol
+ Expand
3

Xenograft Mouse Model for Cancer Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male and female athymic nude mice (CrTac:NCr-Foxn1nu) were purchased from Taconic at age of 4- to 5-week. The mice were housed under pathogen-free conditions with commercial diet, water ad libitum, and 12 h light/12 h dark cycle. The experimental protocol was approved by IACUC of the University of Kentucky based on the NIH guidelines. Two million HCT116 cells were injected s.c. into the flank of each mouse and the tumor size was monitored and determined as previously described.10 (link) When tumors reached 50–150 mm3, mice were randomly divided into four groups (five mice per group) and i.p. injected with (i) vehicle [10% (v/v) DMSO in corn oil); (ii) BMS-754807 (25 mg/kg); (iii) U0126 (15 mg/kg); and (iv) BMS-754807 (25 mg/kg) + U0126 (15 mg/kg) every day for 12 days. All mice under these treatments showed no sign of toxicity, i.e., bodyweight loss more than 15%, diarrhea, or decreased food intake.
+ Open protocol
+ Expand
4

Xenograft Model of Bladder Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using a representative set of two human bladder TCC cell lines that had already been tested in vitro, transplantable EJ-1 or UM-UC-3 tumor xenografts were initially established by the inoculation of 5 × 106 cells harvested from exponentially growing cell culture. For tumor growth experiments, male and female athymic nude mice (24–26 g per mouse; CrTac:NCr-Foxn1nu; obtained from Taconic) were implanted subcutaneously in the rear flank with an EJ-1 or UM-UC-3 tumor fragment (approximately 20–30 mg) using a 13-gauge trocar. Once tumors reached approximately 100 mm3, animals were treated daily for up to 11 (for the EJ-1 tumor) or 15 (for the UM-UC-3 tumor) days with vehicle or dapagliflozin (4 and 20 mg/kg per day in males and 12 and 60 mg/kg per day in females; differing doses between sexes to achieve comparable exposures). Toxicokinetics of dapagliflozin and D3OG were evaluated following daily dosing on day 4 (UM-UC-3 mice) or day 5 (EJ-1 mice). Tumors were measured with calipers twice weekly and tumor volume (mm3) was estimated from the formula tumor weight = (length × width2)/2, where length is the larger and width is the smaller of the perpendicular diameters.
+ Open protocol
+ Expand
5

Athymic Nude Mice for Xenograft Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female athymic nude mice (CrTac NCr-Foxn1nu) between 6 and 8 weeks of age were obtained from Taconic Biosciences (model NCRNU). VilCre Lin28b-low or -high mice were generated by our lab (12 (link)). VilCre mice were purchased from The Jackson Laboratory. All mice were acclimated for 1 week before use. Animal experiments were conducted in accordance with a protocol approved by the Columbia University Institutional Animal Care and Use Committee.
+ Open protocol
+ Expand
6

Rat and Mouse Housing Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Outbred Wistar Unilever (HsdCpb:WU) rats were obtained from Harlan Sprague Dawley (Woudenberg, The Netherlands). Inbred Wistar Furth (WF/NHsd) rats were obtained from Harlan Sprague Dawley (Indianapolis, IN). The rats were housed, two to a cage, on corn cob betting in in solid bottom cages with ad libitum access to food (NIH-07, Zeigler Brothers, Gardners, PA) and tap water. Nude mice (CrTac:NCr-Foxn1nu) were obtained from Taconic (Germantown, NY) and housed in microisolator cages on autoclaved corn cob bedding. When animals being monitored for drinking water consumption, they were single caged. The animals were housed in a standard animal room with a 12–12 hour light dark cycle of the AAALC-accredited satellite animal facility of New York University School of Medicine in Sterling Forest, NY.
+ Open protocol
+ Expand
7

Xenograft Tumor Experiments in Nude Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal studies and procedures were performed in accordance with the Dana-Farber institutional animal care and use committee (IACUC) approved protocols. Male athymic nude mice (CrTac:NCr-Foxn1nu) (Taconic, USA) were used for tumor xenograft experiments. At the time of implantation, mice were 5–7 weeks old and weighed between 20–27 grams.
+ Open protocol
+ Expand
8

Xenograft Assays and JQ1 Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
For xenograft assays 5-6-weeks old female CrTac:NCr-Foxn1nu and NOD.Cg-Prkdcscid Il2rgtm1Sug/JicTac mice were purchased from Taconic. Tumors were induced by bilateral orthotopic mammary fat pad injection of 1×106 cells in 50% Matrigel (BD Biosciences) in DMEM/F12 or Medium 171 (except for IDC50-X cells, which were injected with 3% FBS and 4 mg/ml collagen gel in Medium 171). Animal experiments were conducted following protocol 11-023 approved by the Dana-Farber Cancer Institute Animal Care and Use Committee. For all the xenograft studies, the sample size of each group (5-10 mice) is indicated in the figures. We performed pilot experiments using a few (5-10) mice/group followed by larger studies if needed to reach statistical significance and repeated experiments to ensure reproducibility. Due to the nature of the performed experiments, no randomization and no blinding was used as it was deemed unfeasible. However, the resulting tumors were analyzed in a blinded manner. Mice were administered JQ1 (50mg/kg, daily), vehicle only (control) for 14 days beginning at day 14 (SUM159), or doxycycline at day 21 (SUM159-shBRD4) after injection. Mice were euthanized and tumors evaluated 28 and 60 days after injection of parental and TET-inducible shBRD4-expressing SUM159 cells into mammary fat pads.
+ Open protocol
+ Expand
9

Tongue Tumor Xenograft Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAL27 cells (3 x 105) were injected into the tongues of six-week old female NCr nude mice (CrTac:NCr-Foxn1nu, Taconic, Hudson, NY) as we previously described [32 (link)]. Mice began a daily lavage schedule with 50 μl sesame oil alone or CB7993113 dissolved in sesame oil (50 mg/kg/day in 50 μl) 24 hours before tongue injections. Animals were weighed and tumor size was measured with Vernier calipers over a 26 day period. Animals were sacrificed when mice lost 20% of their total body mass. Surviving mice were sacrificed by day 26. Animals were housed at the Association for Assessment and Accreditation of Laboratory Animal Care-certified Boston University Medical Laboratory Animal Science Center and used in accordance with the NIH Guide for the Care and Use of Laboratory Animals. A Boston University Medical Campus Institutional Animal Care and Use Committee-approved protocol was followed.
+ Open protocol
+ Expand
10

Xenograft Model of Breast Cancer in Nude Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal procedures were performed in accordance with the guidelines and regulations set forth by the Canadian Council on Animal Care and approved by the University of Alberta Health Sciences 2 Animal Care and Use Committee (Protocol # AUP00000386). 3 × 106 cells were injected into the left mammary gland (#4) of nude mice (CrTac:NCr-Foxn1nu, Taconic) in 100 μl of a 1:1 matrigel/media mix. RPMI 1640 medium with no supplemental serum or antibiotic and Corning® Matrigel® Basement Membrane Matrix was used. Docetaxel (10 mg/kg) was administered via intraperitoneal injection on days as indicated. Animals were monitored weekly and sacrificed when tumors reached 20 mm in diameter. Tumors were collected and tumor volume (mm3) was calculated with the formula of (length × width × height)/2. Hematoxylin and eosin staining was performed as previously described7 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!